Kryoprotektanlar ve gamet hcrelerinin dondurulmasinda kryoprotektif etki
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods
A study including 304 peri-menopausal women showed 90% of patients being treated with aromatase inhibitors did not experience the cancer returning after 5 years, in comparison to 78% on tamoxifen treatment
Across the various development stages, from Phase I to pre-registration, 101 different companies have contributed at least one novel drug candidate to the development pipeline, (Figure 3 a), indicative of the perceived opportunity that continues to exist in the medical management of obesity
See our Reconstitution Solution page for laboratory-grade bacteriostatic water
This dual-action medication targets two metabolic hormones instead of one, which is clinically associated with superior efficacy and more significant weight loss outcomes for many patients